![]() |
|
|



*
Craft Technologies, Inc., Wilson, NC 27893, and
Center for Human Nutrition, Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 21205
3To whom correspondence should be addressed.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: vitamin A dried blood spot HPLC filter paper nutritional assessment
| INTRODUCTION |
|---|
|
|
|---|
Conventional VAD monitoring usually involves analysis of serum retinol derived from venous blood by HPLC. The sampling process is invasive and impractical to carryout in a field situation. Typically, venipuncture is required to obtain the volume of blood necessary (>500 µL of whole blood). Due to fear of needles, disease transmission and/or religious beliefs, this factor alone excludes many from participating. Electricity is necessary for centrifugation and long-term freezer storage. Sample collection would be much easier and less invasive if dried blood spots (DBS) could be used. It does not require needles and the potential for disease transmission is minimal. Sample collection requires only a few drops of blood from a finger- or heel-prick. The blood collection cards are easily labeled, transported and stored. Transportation of samples to an analytical laboratory may not require subzero temperatures, thus reducing costs and inconvenience.
The measurement of vitamin A in DBS was first described by Shi et al. (1995)
using high performance capillary electrophoresis (HPCE) with
laser-enhanced fluorescence detection. Using a modification of the
HPCE method of Ma et al. (1993)
, Shi et al. optimized the separation
conditions and improved the reliability of the method. More
importantly, they developed sample preparation methods for the elution
of holo-RBP from DBS, ultimately demonstrating the stability of the
complex in dried blood. This observation was an important milestone
since the holo-RBP complex was thought to be unstable when exposed
to air and iron from the red blood cells. Now vitamin A, like many
other biochemical markers, could be measured in blood samples collected
from a finger- or heel-prick directly onto collection cards.
However, the instrumentation and expertise necessary for the
measurement were not practical for population status assessment.
The purpose of the present study was to develop a protocol for the extraction of retinol from DBS for analysis by HPLC. In addition, we examined the stability of retinol in DBS at three temperatures and provide the initial method validation using HPLC to analyze the samples rather than HPCE.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Retinyl acetate, ascorbic acid, diethylenetriamine pentaacetic acid (DTPA), sodium phosphate, ammonium acetate, triethylamine, BHT and hydroquinone of reagent grade or better were purchased from Sigma Chemical (St. Louis, MO). Acetonitrile, p-dioxane, ethanol, hexane and methanol of HPLC grade were purchased from Curtin Matheson Scientific (Kennesaw, GA). Tocol, used as an internal standard, was generously donated by Hoffman La-Roche (Basel, Switzerland). Retinol was purchased from US Biochemical (Cleveland, OH). Blood spot cards, identical to those used for neonatal screening, were provided by Schleicher and Schuell (cat. #903, Keene, NH).
Sample collection.
Samples of venous blood were collected in vacuum tubes containing EDTA as an anticoagulant. The 17 healthy U. S. volunteers had provided informed consent to participate in a nutrition study. Sample collection cards were spotted with 50 µL aliquots of whole blood; then the remainder of the blood was centrifuged to collect plasma for comparison. This allowed the comparison of a known volume of blood with plasma samples, critical for the experimental stage of method development. These cards were air-dried overnight in a darkened room, then wrapped individually in tissue and placed in zip-closure plastic bags prior to storage at -70°C.
Chromatographic conditions.
The HPLC consisted of a vacuum solvent degasser, quaternary gradient pump, programmable UV/VIS detector fitted with deuterium and tungsten lamps and an autosampler with refrigerated sample compartment and column oven (Thermo Separation Products, San Jose, CA). The column used in the final HPLC method was a Betasil C8, 3 µm, 4.6 x 150 mm, protected with a Javelin Betasil C8, 3 µm guard column (Keystone Scientific, Bellefonte, PA). The mobile phase consisted of methanol/water (95:5, v/v) at a flow rate of 1.0 mL/min. The detector wavelength was set at 325 nm throughout the run (4.6 min). The injection volume was 20 µL.
The HPLC method of Craft (1996)
was used for serum retinol analysis and
DBS retinol analysis during the development of the sample extraction.
It incorporated a Spherisorb ODS2, 3 µm, 4.6 x 150 mm,
protected with a Javelin ODS2, 3 µm guard column (Keystone
Scientific). The mobile phase consisted of
acetonitrile/dioxane/methanol/triethylamine (83:13:4:0.1, v/v/v/v).
Ammonium acetate (150 mmol/L) was present in the methanol component of
mobile phase. The flow rate was 1.2 mL/min for DBS analysis, and 1.5
mL/min for serum analysis and column temperature was maintained at
29°C. The detector was programmed at 325 nm until 3.0 min then at 300
nm until the end of the run (6 min). The wavelength change to 300 nm
was required to measure tocol as the internal standard. The injection
volume was 20 µL.
Methods.
A 0.635 cm (1/4 inch) disk was punched from the center of the DBS on the collection card. A standard hole-punch was used ensuring the same quantity of filter paper was removed from sample to sample. During the development stage, whole DBS consisting of 50 µL aliquots were used, and the entire spot was cut out to ensure a known quantity of blood. The punched spot was placed in a 10 x 75 mm borosilicate test tube, and 1 mL of buffer was added. The final buffer consisted of 150 mmol/L phosphate buffer, pH 7.8, containing 57 mmol/L (10 g/L) ascorbic acid and 2 mmol/L DTPA. The sample in buffer was sonicated 15 min in an ultrasonic bath (Branson Model 1210, Danbury, CT), then 100 µL of internal standard and 900 µL of ethanol containing 100 mmol/L BHT and 50 mmol/L hydroquinone, as antioxidants, were added followed by vortex mixing for 20 s. A 2-mL portion of hexane was added and vortex-mixed for 1 min. The tube was centrifuged at 500 x g for 1 min to separate the phases. The hexane layer was removed and the extraction repeated. The combined hexane layers were evaporated under a nitrogen stream and dissolved in 60 µL of mobile phase by sonicating 10 s and vortex mixing 30 s. The reconstituted sample was placed in a conical insert before HPLC analysis.
Calibration.
Standards of retinol, retinyl acetate and tocol were prepared in ethanol. The stock retinol concentration was calculated based on Beers Law using an absorptivity of 1850 Ecm1%at 325 nm. The spectroscopic concentration was corrected for purity as determined by HPLC. A multiple point, internal standard, calibration curve was generated using the ratio of peak areas. Both plasma and matching blood spots were analyzed for retinol by HPLC. A "recovery/volume adjustment" factor (plasma retinol/DBS retinol) was calculated for a subset of samples. The median of these ratios was used to adjust the concentration of DBS retinol to values equivalent to plasma retinol. We also estimated the plasma volume of a punched sample by analyzing both a 50 µL DBS and 0.635 cm punch from the same individual and correcting for packed red blood cell volume.
Experimental Procedures.
DBS and plasma from 17 healthy subjects were analyzed for retinol by HPLC. Adjusted DBS retinol values were plotted against plasma retinol values to determine the correspondence between the two data sets.
Three different sets of DBS were placed in separate envelopes and maintained at 25, 4, and -20°C. Samples from each set were analyzed in duplicate on d 1, 2, 3, 6, 15, 30 and 80. Specimens for two of the sets were freshly collected at the lab, dried and immediately analyzed to determine time 0 DBS retinol concentrations. The remaining specimen was from the Center for Disease Controls Neonatal Screening Program (Atlanta, GA) and had been stored in sealed foil pouches at -70°C for ~2 y before this analysis.
Statistical analysis.
Means and SD for the stability data and correlation coefficients comparing the adjusted DBS retinol to the plasma retinol were determined using Microsoft Excel version 6.0 (Microsoft Corporation, Redmond, WA). Confidence limits were determined to ascertain if the regression line for plasma vs. DBS retinol differed from unity. A line having a slope of zero is a horizontal line and is indicative of no change over time. Therefore, DBS retinol values were deemed "homeostatic" when the confidence limits of the change in the slope of DBS retinol concentration vs. time encompassed zero.
| RESULTS |
|---|
|
|
|---|
|
|
|
Figure 4
illustrates the comparison of plasma retinol to DBS retinol from 17
healthy U. S. volunteers. The correlation between plasma retinol
and DBS retinol for these well-controlled samples was 0.90, and the
line of identity was within the confidence intervals of the regression
line for plasma retinol vs. DBS retinol.
|
| DISCUSSION |
|---|
|
|
|---|
The relative dose response (RDR) (Loerch et al. 1979
)
and the modified dose response (MRDR) (Tanumihardjo et al. 1990
, 1996
) have been used to measure body
stores of vitamin A. Although these techniques are less susceptible to
problems such as hemolysis and inflammation, Russell et al. (1982)
pointed out the problem of using the RDR in individuals with protein
malnutrition, a common companion of VAD in many developing countries.
In addition, both techniques necessitate a time interval (~5 h) from
dosing with vitamin A or didehydroretinol until the final blood draw.
The RDR requires two blood samples while the MRDR requires only one
draw. As in the Futterman method, the collection of whole blood
necessitates centrifugation, low-temperature storage and the
ability to transport frozen specimens. In 1993 Oliver et al. briefly
reported successfully using serum samples spotted on filter paper for
the analysis of retinol by HPLC. They not only demonstrated the
feasibility of using filter paper-immobilized samples as a matrix
for retinol analysis but also that the holo-RBP complex was stable
in immobilized serum for at least 5 mo. The authors did not discuss the
storage conditions under which the samples were maintained prior to
analysis. This method is limited by the rather large 200 µL serum
sample and the fact that the use of whole blood was not examined.
When Shi et al. (1995)
demonstrated the capability to measure
holo-RBP in DBS, the door was opened for much more convenient and
far-reaching sample collection. Our newly developed method builds
on their demonstration that retinol remains stable in DBS. It has been
optimized to efficiently extract and preserve retinol from DBS. As
such, it measures free retinol in the same manner as HPLC methods for
plasma retinol. Thus many of the limitations of the HPCE method for
analysis of holo-RBP in DBS have been overcome, e.g.,
instrumentation availability, technical expertise and errant sample
values.
The set of DBS that was analyzed for retinol concentrations and
compared to corresponding plasma values came from ideal collection
conditions. The blood collection cards from Johns Hopkins had been
spotted and handled in accordance with the accepted guidelines for such
specimens (Hannon et al. 1992
) and maintained at
-70°C. Both plasma retinol and DBS retinol were performed at the
same location using the same equipment and methodology.
Since no DBS control samples are commercially available with known
concentrations of retinol, comparable to National Institute of
Standards and Technology (NIST) Standard Reference Material 968:
Fat-Soluble Vitamins in Human Serum, (NIST, 1995
) the
accuracy of the DBS method is improved if a subset of plasma samples
with matching DBS is available to serve as calibrators. Both plasma and
DBS retinol are determined in the matched samples and a
"recovery/volume adjustment" factor is determined which permits the
DBS retinol concentration to be expressed as plasma retinol. This
factor adjusts the DBS retinol concentrations for the volume of plasma
in the DBS sample and the extraction efficiency. Due to the novelty of
the technique, this is deemed as a necessary precaution since
variations in sample collection and populations have not yet been
established. Thus far, the median factors from different populations
have varied by < 10%. With further validation and the
availability of quality control specimens, it may be unnecessary to
include any plasma samples with DBS analysis.
Slight variations of this method have been used to measure DBS samples from the USA, Nepal, Bangladesh, Liberia and Guatemala. The HPLC method using the C8 column must be flushed daily with a lipophilic solvent, such as tetrahydrofuran, to elute strongly retained contaminants. DBS samples from CDCs Neonatal Screening Program stored at -70°C were used as QC samples for larger studies and found to be very stable and reproducible.
Our initial attempt to examine the stability of retinol in DBS at
various temperatures revealed that the measured retinol concentration
in freshly prepared DBS declined for 610 d at all temperatures tested
(See Fig. 3
). At this point the "fresh" samples appear to have
reached "homeostasis" and remained constant through d 80. However,
samples held at ambient temperature plateaued at a slightly lower
concentration. These data indicate an apparent initial degradation or
change in extraction efficiency, followed by considerable stability.
The measured retinol concentration in "aged" CDC samples remained
constant at all temperatures throughout the 80 d.
This is the first report on the development of methodology to measure retinol in DBS using HPLC. In light of the strong correlation between plasma and DBS retinol and the stability observed beyond the homeostatic point, the authors feel it will serve as a useful approach to assess vitamin A status of populations. However, more research is needed to understand the initial decline in the measured concentration of retinol in DBS samples and to determine conditions under which samples should be stored. Many cultures or high-risk subgroups, such as children, who would not participate in venous blood samplings, will become accessible by way of DBS.
The authors wish to appropriately caution those attempting to implement this DBS methodology. The DBS punch contains the equivalent of ~1012 µL of plasma and less than half is injected for HPLC analysis. It should only be attempted incorporating all the components detailed above using an optimized HPLC system with a highly sensitive detector set at the wavelength maximum of retinol.
| FOOTNOTES |
|---|
2 Supported by grants from Office of Health and Nutrition, USAID, Washington, D. C. and Task Force Sight and Life, Basel, Switzerland. ![]()
4 Abbreviations used: CDC, Center for Disease Control; DBS, dried blood spot; DTPA, diethylenetriaminepentaacetic
acid; HPCE, high-performance capillary electrophoresis; MRDR, modified relative dose response; NIST, National Institute of Standards
and Technology; RBP, retinol binding protein; RDR, relative dose response; VAD, vitamin A deficiency. ![]()
Manuscript received August 6, 1999. Initial review completed September 15, 1999. Revision accepted December 7, 1999.
| REFERENCES |
|---|
|
|
|---|
1. Craft N. E. High resolution HPLC method for the simultaneous analysis of carotenoids, retinoids and tocopherols. FASEB J. 1996;10:527abs#3039
2. Futterman S., Swanson D., Kalina R. E. A new rapid fluorometric determination of retinol in serum. Invest. Opthalmol. 1975;14:125-130
3. Hannon W. H., Aziz K. J., Collier F. C., Fisher D. A., Fafara C. E., Knight W. S., Mitchell M. L., Sideman L., Therell , Jr B. L., Wolfson M. Blood collection on filter paper for neonatal screening programs Second edition. 1992:NCCLS Document LA4A2 vol. 12 no. 13
4. Loerch J. D., Underwood B. A., Lewis K. C. Response of plasma levels of vitamin A to a dose of vitamin A as an indicator of hepatic vitamin A reserves in rats. J. Nutr. 1979;109:778-786
5. Ma Y., Wu Z., Furr H. C., Lammi-Keefe C., Craft N. E. Fast minimicroassay of serum retinol (vitamin A) by capillary zone electrophoresis with laser-excited fluorescence detection. J. Chromatogr. B 1993;616:31-37
6.
Marinovic A. C., May W. A., Sowell A. L., Khan L. K., Huff D. L., Bowman B. A. Effect of hemolysis on serum retinol as assessed by direct fluorometry. Am. J. Clin. Nutr. 1997;66:1160-1164
7. National Institute of Standards and Technology. (1995) Certificate of Analysis: Standard Reference Material 968b, Fat-Soluble Vitamins and Cholesterol in Human Serum. Gaithersburg, MD: NIST Standard Reference Materials Program.
8. Oliver R. W. A., Kafwembe E. M., Mwandu D. Stability of vitamin A circulating complex in spots of dried serum samples absorbed onto filter paper. Clin. Chem. 1993;39:1744-1745[Medline]
9. Russell R. M., Iber F. L., Bustin M., Goldberg N., Miller P., Krasinski S. D. Failure of the relative dose response test (RDR) to predict vitamin A (VA) deficiency in patients with protein calorie malnutrition. Am. J. Clin. Nutr. 1982;35:857
10. Semba R. D., Miooti P. G., Chiphangwi J. D., Saah A. J., Canner J. K., Dallabetta G. A., Hoover D. R. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343:1593-1597[Medline]
11. Shi H., Ma Y., Humphrey J. H., Craft N. E. Determination of vitamin A in dried human blood spots by high-performance capillary electrophoresis with laser-excited fluorescence detection. J. Chromatogr. B 1995;665:89-96[Medline]
12.
Sommer A., Katz J., Tarwotjo I. Increased risk of respiratory disease and diarrhea in children with pre-existing mild vitamin A deficiency. Am. J. Clin. Nutr. 1984;40:1090-1095
13.
Tanumihardjo S. A., Cheng J.-C., Permaesih D., Muherdiyantiningsih , Rustan E., Muhilal , Karyadi D., Olson J. A. Refinement of the modified-relative-dose-response test as a method for assessing vitamin A status in a field setting: Experience with Indonesian children. Am. J. Clin. Nutr. 1996;64:966-971
14. Tanumihardjo S. A., Furr H. C., Erdman J. W., Jr, Olson J. A. Use of the modified relative dose response (MRDR) assay in rats and its application to humans. Eur. J. Clin. Nutr. 1990;44:219-224[Medline]
15. Underwood B., Arthur P. The Contribution of Vitamin A to Public Health. FASEB J 1996;10:1040-1048[Abstract]
This article has been cited by other articles:
![]() |
N. Potischman Biologic and Methodologic Issues for Nutritional Biomarkers J. Nutr., March 1, 2003; 133(3): 875S - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Erhardt, N. E. Craft, F. Heinrich, and H. K. Biesalski Rapid and Simple Measurement of Retinol in Human Dried Whole Blood Spots J. Nutr., February 1, 2002; 132(2): 318 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Coté Noninvasive and Minimally-Invasive Optical Monitoring Technologies J. Nutr., May 1, 2001; 131(5): 1596S - 1604. [Abstract] [Full Text] |
||||
![]() |
N. E. Craft Innovative Approaches to Vitamin A Assessment J. Nutr., May 1, 2001; 131(5): 1626S - 1630. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||